Introducing Atlas®: Multi-organ Phenotyping in Non-alcoholic Steatohepatitis (NASH)
Date: 13 November 2020
Time: 4:30pm GMT | 11:30am ET
Atlas® is a metabolic imaging suite redefining multi-organ assessment for clinical trials in diabetes and metabolic disease. It provides quantitative metrics of health and function across multiple organs from a single 30-minute, non-contrast MR scan. The utility of Atlas will be presented in a series of webinars throughout TLMdX 2020.
- Current issues in liver disease trials
- How Body Comp metrics are being used to solve some of these
- The future of using multi-organ imaging in liver trials